MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising malaria vaccine trial launches in africa
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new malaria vaccine (PfSPZ-LARC2) in 180 healthy adults aged 18-50 in Burkina Faso. The vaccine uses weakened malaria parasites that stop growing in the liver, so they cannot cause blood-stage infection. Participants receive either one or two doses of the vacci…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:25 UTC
-
Wearable tech aims to sniff out malaria before symptoms strike
Diagnosis Not yet recruitingThis early-phase study tests whether wearable biosensors (like a wristband or earphones) can detect malaria infection before symptoms appear. Thirty-two healthy adults will be exposed to the malaria parasite or a placebo in a controlled setting. Researchers will compare the devic…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated May 22, 2026 13:52 UTC
-
New malaria shot could offer months of protection
Prevention Not yet recruitingThis study tests a new long-acting injection called MMV371 to see if it can safely prevent malaria. About 80 healthy people aged 12 to 50 in Rwanda will get either the study drug or a placebo. Researchers will check for side effects and measure drug levels in the body over 24 wee…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated May 20, 2026 11:53 UTC